Purpose: Findings not associated with thromboembolic disease on routine perfusion lung scan may sometimes have particular clinical significance. We wanted to assess the clinical importance and overall survival after the recognition of a lymphangitic carcinomatosis pattern on perfusion lung scan. Case report: We report a case of lymphangitic carcinomatosis pattern on perfusion lung scan performed in a previously healthy patient who had rapid progressive course and died the next day. Method: A Medline search of case reports that describes either lymphangitic carcinomatosis or tumour microemboli on perfusion lung scan. Results: There were a total of 32 patients identified in 21 articles from various countries, including our case. The studied perfusion pattern was reported more often in female patients (81%) was associated with a progressive history of dyspnea (69%) and normal or mild findings on chest radiograph (58%). Of the 29 patients with available outcome data, 79% (23/29) had a progressive course after the lung scan interpretation. In 18 of these 23 cases, the actual interval of survival was given: 67% of these patients (12/18) died within the first month. Discussion: A lymphangitic carcinomatosis perfusion pattern on scintigraphic imaging is associated with a poor prognosis. Nuclear medicine physicians should be aware of this association and that raising the suspicion for a metastatic process may make a difference in the treatment plan of these patients.
Perfusion lung scan interpretation is certainly an important part of the daily clinical work of most nuclear medicine departments. Findings not associated with acute thromboembolic disease, although infrequent and mostly benign in nature, should be recognized because they may have particular clinical significance as exemplified in this case report. We recently encountered a case of a lymphangitic carcinomatosis pattern on a perfusion lung scan. This particular imaging pattern is well known to nuclear medicine physicians, although the full clinical consequence of such interpretation may be less well understood. We present the case of a previously healthy patient who experienced rapid deterioration of her condition and died the day after the perfusion lung scan. This unfortunate chain of events triggered a review of the medical literature to ascertain the role of nuclear medicine when assessing the so-called lymphangitic carcinomatosis perfusion pattern. Prognostic inference from the analysis performed by the authors should give the reader a sense of the urgency to promptly report these cases to the referring physician.
Case Report
A 34-year-old female patient presented to the emergency department with exacerbation of a progressive history of dyspnea, fatigue, and night sweats. There was no relevant medical history and no significant thromboembolic risk factors, and she was a lifetime nonsmoker. Because she had already sought medical attention on 3 occasions with no relief of her symptoms, the emergency physician ordered a ventilation/perfusion (V/Q) lung scan to exclude an atypical pulmonary embolism presentation.
The ventilation images showed homogeneous distribution of the aerosols to both lungs, with no significant proximal airway visualisation to suggest significant turbulent airways disease such as bronchospasm or chronic obstructive pulmonary disease. The perfusion images (Figure 1 ) demonstrated multiple small peripheral perfusion defects to both lungs and involved evenly both the upper and lower lung zones. The impression of the lung scan report states that this pattern of perfusion deficits was suspicious for lymphangitic carcinomatosis. The treating physician was directly called and a computed tomography (CT) of the chest was recommended.
Within the next hour, the patient underwent a sequential CT of the head and neck, chest, abdomen, and pelvis, because small palpable lymph nodes were found in the left cervical area on physical examination and based on a working diagnosis of possible diffuse lymphoma. The CT angiography of the chest revealed no pulmonary embolism, no significant lung parenchyma abnormalities, no pleural effusions, and no mediastinal lymphadenopathy. The CT of the neck showed few small lymph nodes along the anterior and posterior left cervical space and in the left supraclavicular region. There also were very few nodes seen along the posterior right cervical space. The CT of the abdomen and pelvis demonstrated prominent retroperitoneal lymphadenopathies along the periaortic, interaortocaval, and celiac axis, and in the porta hepatis regions.
At that point, the patient was hospitalized. The following night, the respiratory status of the patient continued to deteriorate rapidly. Although she was transferred to the intensive care unit with maximal medical therapy and ventilation support, she died the next morning before chemotherapy could be initiated. The final pathology report of the autopsy confirmed the diagnosis of high-grade lymphoma with multiple and extensive pulmonary tumour microemboli to both lungs.
Methods
To assess the prognostic implication of this imaging interpretation, a systematic review of the medical literature was performed. A Medline search of ''lymphangitic carcinomatosis and perfusion lung scan'' returned only 8 studies [1e8]. A search for ''tumor embolism and perfusion lung scan'' returned 40 articles. From the available abstracts, only those studies that describe diffuse subsegmental or multiple peripheral perfusion defects were included, which yielded 10 new articles [9e18]. Two additional case reports were included after reading of the references of the other articles [19, 20] .
Thus, we have included, from the available literature, 20 articles from various countries: 16 in English, 1 in Dutch, and 3 in Japanese. The 4 non-English articles were analysed based on their very complete English abstract in 2 cases, from the gracious participation of their researchers contacted by e-mail for 1 article and from the translation of the original article in the last one. All articles but 3 were full case reports with variable information on the clinical presentation and outcome of the described patients. Three articles were published as ''Interesting Images,'' with only a brief description of the imaging findings and pathology when available.
The following data were collected for each patient reported: age, sex, oncologic history, initial clinical presentation, available chest radiograph or chest CT results, a description of the V/Q lung scan, clinical outcome, and definite histologic information from either lung tissue sample or autopsy report with respect to the lung parenchyma process.
Results
The review of these articles is striking in that the ''fragmented perfusion'' or ''lymphangitic carcinomatosis'' pattern was mainly reported in women and that the survival was extremely poor (Table 1) . A total of 32 patients were identified from the literature, including our case. The majority, 81%, were female patients (26/32), and the age at the time of presentation ranged from 30-81 years old (average, 53 AE 13 years old).
Three patients did not have significant oncologic history but were found at autopsy to have had pancreatic carcinoma (1 case), adenocarcinoma of unknown primary (1 case), and diffuse high-grade lymphoma (1 case). One patient was diagnosed with metastatic squamous cell carcinoma of the right lower lobe bronchus with right ventricle and pulmonary metastases at the time of presentation. The remaining 28 patients (90% [28/32]) had known cancer at the time of presentation: breast carcinomas (21 cases), gastric carcinomas (4 cases), ovarian adenocarcinoma (1 case), prostate carcinoma (1 case), and non-Hodgkin lymphoma (1 case). Thus, the majority of these patients had tumour from an epithelial origin (94% [30/32]) as opposed to tumour of hematogenous origin in 6% (2/32), and none of sarcomatous origin.
Most patients (69% [22/32]) had a history of progressive dyspnea over a few weeks. The other patients had a rapid onset of dyspnea (4/32); a clinical presentation only described as dyspnea or shortness of breath, with no information on the progression of those symptoms (4/32); deterioration of the radiologic images (1/32); or atypical thrombotic thrombocytopenic purpura-like syndrome (1/32). Except for 1 case report, all the other cases mentioned results of initial radiologic evaluation. In 58% of these (18/31), the initial chest radiograph or CT chest was reported as being normal or near normal.
With regard to the outcome and the survival time after recognition of the scintigraphic pattern on the perfusion lung scan, the reported periods are as follows ( Figure 2) . In 3 patients, the outcomes were not communicated. Six patients survived more than a month based on the follow-up information available: one progressed as an outpatient (the interval of follow-up was not specified), 1 patient survived at least 1 month, 1 patient survived 3 months, 1 patient survived 4 months, and 2 patients survived 1 year. The cause of the eventual deaths of these 6 cases was not communicated, but their contribution to the survival assessment after the perfusion lung scan was considered in the survival curve analysis.
The majority (79% [23]) of the 29 patients with available outcome information experienced a progressive course after the perfusion lung scan interpretation. In only 18 of these 23 cases was the actual interval of survival given. The survival distribution of these 18 cases ranged from 1 day to 3 months, with an average of 25.9 AE 30.7 days; 67% of patients (12/18) died within the first month and 78% within the first 2 months (14/18) after recognition of the abnormal perfusion pattern.
Although a more thorough statistical analysis could not be performed from these incomplete values, a simple observation can be made because that lymphangitic carcinomatosis perfusion pattern on scintigraphic imaging is highly indicative of a poor prognostic. A Kaplan-Meier survival curve ( Figure 3 ) was built by taking in consideration the 5 cases with known follow-up periods and the 18 patients with a reported interval time of death. The initial rapid decline of cumulative survival rate was followed by a progressive decline in the cumulative survival rate, with a cumulative survival rate that decreased below 50% at 21 days after the recognition of the lymphangitic carcinomatosis perfusion pattern.
Discussion
In the early 1970s, Pendergrass et al [19] reported a case of unusual lung perfusion changes, described as peripherally radiating irregular and linear perfusion defects in addition to clearly demonstrated fissure hypoperfusion defects. To our knowledge, this was the first study to link this perfusion pattern on nuclear medicine imaging with tumour occlusion of pulmonary vessels and lymphatics. Three cases of lymphangitic pulmonary metastases were described in the article of Sadoff et al [20] in 1976. The term ''lymphangitic carcinomatosis'' in relation to an abnormal perfusion lung scan was first mentioned in an article by Green et al [1] , also in 1976. They described 4 patients with breast cancer and pathologyproven lymphangitic metastases of the lungs. From these, 2 had normal chest radiographs, and 3 had normal ventilation lung scans. The perfusion pattern of all the patients, however, was abnormal, with irregular peripheral defects.
Results of previous studies also proposed widespread occlusion of pulmonary vessels and lymphatics by tumour [19] and by pulmonary microemboli [20, 21] . After these initial works, further refinement of the diagnostic interpretation of such perfusion abnormalities have been proposed by Sostman et al [2] to differentiate lymphangitic carcinomatosis from multiple thromboemboli. They report 2 patients with a perfusion lung scan that demonstrated ''contour mapping'' of the segments. They proposed that, in carcinomatosis, the perfusion deficits should be smaller, more numerous, and outline the bronchopulmonary segments. In multiple thromboemboli, the defects should be segmental or subsegmental in distribution.
Crane et al [10] believe the pattern to be primarily the result of the vascular emboli and peripheral arterial occlusion, and that lymphangitic spread to represent a complication of tumour microemboli. They propose a combination of findings to distinguish usual thromboembolic disease from tumour microemboli: smaller defects, more numerous, peripherally located, distributed more or less evenly throughout both lungs.
We believe that our case report is the first to highlight the importance of recognizing this typical perfusion pattern of lymphangitic carcinomatosis on perfusion lung scan, even in patients who are unlikely to have such a diagnosis. The review of the literature reveals that this pattern was reported more often in female patients; that the age of the patients at presentation was distributed in a wide range; and that this was usually associated with a progressive history of dyspnea, with normal or mild findings on conventional radiographic evaluation. Although the quality of this review is hampered by the heterogeneous information available and its retrospective design, a simple observation can be made because the fragmented perfusion pattern on scintigraphic imaging is highly indicative of a poor prognosis. This observation should be confirmed by larger prospective studies.
Conclusion
Whether it is called lymphangitic carcinomatosis, fragmented perfusion, or a diffuse tumour microemboli perfusion pattern, we believe that recognition of such an imaging configuration by the nuclear medicine physician should be accompanied by prompt delivery of the report to the treating physician with a mention of the poor prognosis associated with this pattern. It also is interesting to note that patients who survive the initial weeks after such a diagnosis had received prompt empiric chemotherapy. Without recommending such an aggressive approach in a routine practice, it may be useful to keep in mind that being diligent and raising the suspicion for a metastatic process may make the difference in the treatment plan of patients referred to nuclear medicine for otherwise routine pulmonary thromboembolic disease assessment.
